Annual FCF
-$9.56 M
-$4.01 M-72.21%
31 December 2023
Summary:
Sunshine Biopharma annual free cash flow is currently -$9.56 million, with the most recent change of -$4.01 million (-72.21%) on 31 December 2023. During the last 3 years, it has fallen by -$8.90 million (-1352.29%). SBFMW annual FCF is now -306216.78% below its all-time high of -$3122.00, reached on 31 July 2007.SBFMW Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.97 M
+$3.18 M+61.74%
30 September 2024
Summary:
Sunshine Biopharma quarterly free cash flow is currently -$1.97 million, with the most recent change of +$3.18 million (+61.74%) on 30 September 2024. Over the past year, it has dropped by -$1.50 million (-320.07%). SBFMW quarterly FCF is now -216198.57% below its all-time high of -$911.00, reached on 31 January 2009.SBFMW Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$14.00 M
-$1.50 M-12.01%
30 September 2024
Summary:
Sunshine Biopharma TTM free cash flow is currently -$14.00 million, with the most recent change of -$1.50 million (-12.01%) on 30 September 2024. Over the past year, it has dropped by -$4.88 million (-53.47%). SBFMW TTM FCF is now -199882.83% below its all-time high of -$7000.00, reached on 31 October 2007.SBFMW TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SBFMW Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.2% | -320.1% | -53.5% |
| 3 y3 years | -1352.3% | -228.0% | -621.2% |
| 5 y5 years | -1698.8% | -2189.9% | -2844.1% |
SBFMW Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1352.3% | at low | -531.3% | +61.7% | -665.3% | at low |
| 5 y | 5 years | -1825.5% | at low | -6249.4% | +61.7% | -4665.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +61.7% | <-9999.0% | at low |
Sunshine Biopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.97 M(-61.7%) | -$14.00 M(+12.0%) |
| June 2024 | - | -$5.15 M(+32.6%) | -$12.50 M(+9.4%) |
| Mar 2024 | - | -$3.88 M(+29.8%) | -$11.42 M(+19.4%) |
| Dec 2023 | -$9.56 M(+72.2%) | -$2.99 M(+538.1%) | -$9.56 M(+4.8%) |
| Sept 2023 | - | -$469.08 K(-88.5%) | -$9.12 M(-6.7%) |
| June 2023 | - | -$4.07 M(+100.8%) | -$9.78 M(+55.7%) |
| Mar 2023 | - | -$2.03 M(-20.5%) | -$6.28 M(+13.0%) |
| Dec 2022 | -$5.55 M(+203.6%) | -$2.55 M(+127.1%) | -$5.55 M(+67.6%) |
| Sept 2022 | - | -$1.12 M(+95.8%) | -$3.31 M(+18.7%) |
| June 2022 | - | -$573.80 K(-56.0%) | -$2.79 M(-1.6%) |
| Mar 2022 | - | -$1.30 M(+317.9%) | -$2.84 M(+55.0%) |
| Dec 2021 | -$1.83 M(+177.8%) | -$312.11 K(-48.1%) | -$1.83 M(-5.8%) |
| Sept 2021 | - | -$600.81 K(-2.9%) | -$1.94 M(+32.8%) |
| June 2021 | - | -$618.85 K(+108.1%) | -$1.46 M(+58.0%) |
| Mar 2021 | - | -$297.36 K(-29.9%) | -$924.81 K(+40.4%) |
| Dec 2020 | -$658.49 K(+32.6%) | -$424.06 K(+249.4%) | -$658.49 K(+81.3%) |
| Sept 2020 | - | -$121.38 K(+48.0%) | -$363.13 K(+10.8%) |
| June 2020 | - | -$82.02 K(+164.3%) | -$327.80 K(+11.6%) |
| Mar 2020 | - | -$31.03 K(-75.9%) | -$293.73 K(-40.9%) |
| Dec 2019 | -$496.66 K(-6.6%) | -$128.70 K(+49.6%) | -$496.66 K(+4.5%) |
| Sept 2019 | - | -$86.05 K(+79.5%) | -$475.49 K(-3.6%) |
| June 2019 | - | -$47.95 K(-79.5%) | -$493.30 K(-16.7%) |
| Mar 2019 | - | -$233.96 K(+117.6%) | -$592.38 K(+11.4%) |
| Dec 2018 | -$531.66 K(-2.8%) | -$107.53 K(+3.5%) | -$531.66 K(-16.6%) |
| Sept 2018 | - | -$103.86 K(-29.4%) | -$637.33 K(-3.3%) |
| June 2018 | - | -$147.03 K(-15.1%) | -$659.36 K(+7.7%) |
| Mar 2018 | - | -$173.24 K(-18.7%) | -$612.44 K(+11.9%) |
| Dec 2017 | -$547.24 K(+72.3%) | -$213.20 K(+69.4%) | -$547.24 K(+49.4%) |
| Sept 2017 | - | -$125.89 K(+25.8%) | -$366.33 K(+20.7%) |
| June 2017 | - | -$100.11 K(-7.3%) | -$303.43 K(-11.8%) |
| Mar 2017 | - | -$108.04 K(+234.6%) | -$344.06 K(+8.3%) |
| Dec 2016 | -$317.62 K | -$32.29 K(-48.7%) | -$317.62 K(-74.6%) |
| Sept 2016 | - | -$62.99 K(-55.2%) | -$1.25 M(-3.3%) |
| June 2016 | - | -$140.74 K(+72.5%) | -$1.30 M(-11.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$81.60 K(-91.6%) | -$1.46 M(-2.1%) |
| Dec 2015 | -$1.49 M(+176.9%) | -$967.52 K(+814.1%) | -$1.49 M(+109.6%) |
| Sept 2015 | - | -$105.84 K(-65.3%) | -$711.44 K(+4.1%) |
| June 2015 | - | -$304.89 K(+169.8%) | -$683.65 K(+21.9%) |
| Mar 2015 | - | -$113.00 K(-39.8%) | -$560.81 K(+4.1%) |
| Dec 2014 | -$538.60 K(-4.6%) | -$187.71 K(+140.5%) | -$538.60 K(+37.9%) |
| Sept 2014 | - | -$78.05 K(-57.1%) | -$390.63 K(-1.9%) |
| June 2014 | - | -$182.05 K(+100.5%) | -$398.22 K(+26.2%) |
| Mar 2014 | - | -$90.78 K(+128.4%) | -$315.46 K(-44.1%) |
| Dec 2013 | -$564.40 K(+43.6%) | -$39.75 K(-53.6%) | -$564.40 K(-19.1%) |
| Sept 2013 | - | -$85.64 K(-13.7%) | -$697.43 K(-9.7%) |
| June 2013 | - | -$99.28 K(-70.8%) | -$772.11 K(+10.6%) |
| Mar 2013 | - | -$339.72 K(+96.6%) | -$698.02 K(+77.6%) |
| Dec 2012 | -$393.05 K(+32.2%) | -$172.78 K(+7.8%) | -$393.05 K(+16.3%) |
| Sept 2012 | - | -$160.33 K(+536.4%) | -$338.06 K(+14.2%) |
| June 2012 | - | -$25.19 K(-27.5%) | -$296.10 K(+2.9%) |
| Mar 2012 | - | -$34.76 K(-70.5%) | -$287.73 K(-3.2%) |
| Dec 2011 | -$297.30 K(-14.6%) | -$117.78 K(-0.5%) | -$297.30 K(-29.9%) |
| Sept 2011 | - | -$118.37 K(+603.7%) | -$423.88 K(+35.1%) |
| June 2011 | - | -$16.82 K(-62.1%) | -$313.65 K(+1.3%) |
| Mar 2011 | - | -$44.33 K(-81.9%) | -$309.68 K(-11.1%) |
| Dec 2010 | -$348.32 K(+1165.1%) | -$244.36 K(+2900.8%) | -$348.32 K(+235.0%) |
| Sept 2010 | - | -$8143.00(-36.6%) | -$103.97 K(-81.6%) |
| June 2010 | - | -$12.85 K(-84.5%) | -$564.98 K(+2.1%) |
| Mar 2010 | - | -$82.98 K(-82.3%) | -$553.63 K(+16.9%) |
| Oct 2009 | - | -$469.15 K(>+9900.0%) | -$473.49 K(+4530.7%) |
| July 2009 | - | -$1499.00(-22.2%) | -$10.22 K(-35.1%) |
| Apr 2009 | - | -$1927.00(+111.5%) | -$15.76 K(-35.2%) |
| Jan 2009 | - | -$911.00(-84.5%) | -$24.32 K(-8.0%) |
| Oct 2008 | - | -$5888.00(-16.2%) | -$26.42 K(-4.0%) |
| July 2008 | -$27.53 K(+781.9%) | -$7029.00(-33.0%) | -$27.53 K(+34.3%) |
| Apr 2008 | - | -$10.49 K(+247.9%) | -$20.50 K(+104.7%) |
| Jan 2008 | - | -$3015.00(-56.9%) | -$10.02 K(+43.1%) |
| Oct 2007 | - | -$7000.00 | -$7000.00 |
| July 2007 | -$3122.00 | - | - |
FAQ
- What is Sunshine Biopharma annual free cash flow?
- What is the all time high annual FCF for Sunshine Biopharma?
- What is Sunshine Biopharma annual FCF year-on-year change?
- What is Sunshine Biopharma quarterly free cash flow?
- What is the all time high quarterly FCF for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly FCF year-on-year change?
- What is Sunshine Biopharma TTM free cash flow?
- What is the all time high TTM FCF for Sunshine Biopharma?
- What is Sunshine Biopharma TTM FCF year-on-year change?
What is Sunshine Biopharma annual free cash flow?
The current annual FCF of SBFMW is -$9.56 M
What is the all time high annual FCF for Sunshine Biopharma?
Sunshine Biopharma all-time high annual free cash flow is -$3122.00
What is Sunshine Biopharma annual FCF year-on-year change?
Over the past year, SBFMW annual free cash flow has changed by -$4.01 M (-72.21%)
What is Sunshine Biopharma quarterly free cash flow?
The current quarterly FCF of SBFMW is -$1.97 M
What is the all time high quarterly FCF for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly free cash flow is -$911.00
What is Sunshine Biopharma quarterly FCF year-on-year change?
Over the past year, SBFMW quarterly free cash flow has changed by -$1.50 M (-320.07%)
What is Sunshine Biopharma TTM free cash flow?
The current TTM FCF of SBFMW is -$14.00 M
What is the all time high TTM FCF for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM free cash flow is -$7000.00
What is Sunshine Biopharma TTM FCF year-on-year change?
Over the past year, SBFMW TTM free cash flow has changed by -$4.88 M (-53.47%)